The FDA has signed off on the emergency use of PerkinElmer’s (PKI -1.0%) EURORealTime SARS-CoV-2 molecular test for use during the COVID-19 pandemic. The nod is the third for the company.
https://seekingalpha.com/news/3583069-fda-oks-emergency-use-of-third-perkinelmer-covidminus-19-test
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.